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71 bp) that binds the nuclear T3 receptor (TR)
and sterol regulatory element-binding protein-1 (SREBP-1).




 gene to en-
hance T3-induced transcription. Here, we show that treating
hepatocytes with T3 or insulin stimulates a 4-fold increase
in the concentration of the mature, active form of SREBP-1.
When T3 and insulin are added together, a 7-fold increase
in the mature SREBP-1 concentration is observed. Time
course studies indicate that the T3-induced increase in ma-





 transcription and that the mechanism mediating
the effect of T3 on mature SREBP-1 is distinct from that
mediating the effect of insulin. Transfection analyses indi-




 transcription by cAMP or hex-












71 bp. Treatment with cAMP or hexanoate suppresses the
increase in mature SREBP-1 abundance caused by T3 and
insulin.  These results establish a new interaction between
 
the SREBP-1 and TR signaling pathways and provide evidence
that SREBP-1 plays an active role in mediating the effects of
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In livers of avians and mammals, consumption of a high-
carbohydrate, low-fat diet coordinately stimulates the tran-
scription of genes involved in the conversion of carbohydrate












), fatty acid synthase, malic enzyme, and glycerol-3-
phosphate acyltransferase. To date, three signaling pathways
have been identified that mediate the effects of dietary carbo-
hydrate on lipogenic gene transcription. One pathway is acti-
vated by increased glucose metabolism, and its end target is
carbohydrate response factor or carbohydrate response ele-
ment binding protein (ChREBP) (2, 3). Increased glucose









scription (2). A second pathway that signals changes in carbo-





-triiodothyronine (T3), the active form of thyroid hor-
mone (1). T3 activates transcription through its interactions
with nuclear T3 receptors (TRs) bound to T3 response ele-
ments (T3REs) of target genes (4). Functional T3REs have




 (5), fatty acid synthase
(6), and malic enzyme (7). A third pathway that signals alter-
ations in dietary carbohydrate status to lipogenic genes is acti-
vated by insulin, and its end target is sterol regulatory
element binding protein (SREBP)-1 (8, 9). SREBP-1 is synthe-
sized as a 125 kDa precursor protein that is anchored to the
endoplasmic reticulum. To become transcriptionally active,
precursor SREBP-1 is translocated to Golgi, where it is cleaved
by two proteases, resulting in the release of the N-terminal
segment of SREBP-1, referred to as mature SREBP-1. Mature
SREBP-1 is transported into the nucleus, where it binds the





 (10) and fatty acid synthase (11, 12). In rat











phenicol acetyltransferase; CEH, chick embryo hepatocyte; ChREBP,
carbohydrate response element binding protein; HNF-4, hepatocyte
nuclear factor-4; LXR, liver X receptor; PUFA, polyunsaturated fatty
acid; RXR, retinoid X receptor; SRE, sterol regulatory element; SREBP,
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SREBP-1, resulting in an activation lipogenic gene transcrip-
tion (13–15).
The ChREBP, TR, and SREBP-1 signaling pathways also
mediate the effects of nutrients and hormones that inhibit
lipogenic gene transcription. For example, long-chain
fatty acids suppress the activation of ChREBP, TR, and
SREBP-1 by glucose, T3, and insulin, respectively (16–20).
Glucagon, a hormone that signals the starved state in ani-
mals, also inhibits the activation of ChREBP by glucose
(2). Whether glucagon inhibits lipogenic gene transcrip-
tion by suppressing positive signaling through the TR or
SREBP-1 pathways is presently not known.
ACC catalyzes the ATP-dependent carboxylation of
acetyl-CoA to malonyl-CoA, which is the donor of all but
two of the carbon atoms for the synthesis of long-chain
fatty acids. This reaction is the pace-setting step of the
fatty acid synthesis pathway (1). There are two ACC iso-





principal isoform expressed in heart and skeletal muscle,









 is the major iso-
form expressed in tissues such as liver and adipose tissue
that exhibit high rates of fatty acid synthesis. Transcrip-




 gene is subject to nutritional regulation.





 transcription is low; consumption of a high-carbo-










scription caused by dietary carbohydrate is preceded or
paralleled by increases in the molar ratio of insulin/gluca-
gon and the level of T3 in the blood (23). In primary cul-
tures of chick embryo hepatocytes (CEHs), addition of T3





 transcription (24). Insulin has no effect by itself but




 transcription caused by





 transcription caused by T3 and insulin.





 transcription in the presence of T3 and insulin and
do so within 2 h of addition of the fatty acid (25, 26). Hex-
anoate and octanoate per se are not likely to be physiolog-




 transcription, because the levels
of these fatty acids in the blood are not high enough to in-
hibit transcription. However, the potent, rapid, and selec-





scription suggest that the intracellular intermediates and
signaling pathways mediating the effects of these fatty ac-
ids on transcription are physiologically relevant (25). For




transcription is inhibited, increased rates of fatty acid oxi-
dation may cause a change in the level of a metabolic in-





hepatocytes in culture, addition of hexanoate and oc-
tanoate to the culture medium may mimic the effects of
starvation on the level of this intermediate. The identity of
the active intermediate(s) mediating the effects of hex-




 transcription is of interest
because it may aid in the development of new therapies to





 gene is transcribed from two promoters,





lated regions (27). Alterations in the activity of the more
downstream promoter (promoter 2) account for the ma-




 mRNA abundance caused
by starvation and refeeding a high-carbohydrate diet in in-
tact chickens and by T3, insulin, cAMP, and hexanoate in


















 transcription in both the absence
and the presence of T3, with a greater stimulation ob-
served in the presence of T3 (5). The enhancer activity in
the absence of T3 is mediated by the binding of protein
complexes containing liver X receptor (LXR)·retinoid X
receptor (RXR) heterodimers. The increase in enhancer
activity caused by T3 treatment is mediated by the binding
of a different set of protein complexes. One of these com-
plexes contains TR·RXR heterodimers, and another con-






















 transcription in the presence of
T3 (10). Results from transfection, protein binding, and
DNA binding assays suggest that the stimulatory effect of




 transcription is mediated by a direct
and T3-inducible interaction between SREBP-1 and TR
and that this interaction facilitates the formation of a





 gene. Complex formation between TR·RXR and
SREBP-1·SREBP-1 stabilizes the binding of SREBP-1 to the





T3 is dependent on an interaction between TR and




 gene. Both of these signaling path-
ways represent potential targets mediating the actions of





 transcription. The mechanisms by which insulin,





scription remain to be determined.
In the present study, we have identified a new interac-
tion between the SREBP-1 and TR signaling pathways. T3
increases the concentration of the mature, active form of
SREBP-1 in CEH. In addition, we provide evidence that in-























 DNA fragment relative to the transcription start site of




































72 bp have been described previously (10).
pBLCAT2 (pTKCAT) was obtained from B. Luckow and G. Schutz











































 fragment are described in (10).
A full-length cDNA for chicken SREBP-1 was obtained by
screening a chicken liver cDNA library (Stratagene) using a hu-
man SREBP-1 cDNA probe (nucleotides 721 to 1,103 relative to





cDNA ends (RACE) (Y. Zhang and F. B. Hillgartner, unpublished
observations). The N-terminal amino acid sequence of this
chicken SREBP-1 (GenBank accession number: AY029224) more
closely resembles the 1a isoform than the 1c isoform described in




-RACE and RNase protec-
tion analyses indicate that other forms of SREBP-1 containing
variations in the N-terminus are not expressed in chicken cells.
An expression plasmid encoding the mature form of chicken
SREBP-1 was developed by subcloning an SREBP-1 cDNA frag-
ment encoding amino acids 1 to 464 into pSV-SPORT1 (Invitro-
gen) to form pSV-SPORT1-SREBP-1 (1-464).
 
Cell culture and transient transfection
 
Primary cultures of CEH were prepared as previously de-
scribed (30) and maintained in serum-free Waymouth’s medium




M corticosterone, 50 nM insulin (gift









 and 95% air.
CEHs were transfected using a modification of the method of
Baillie et al. (31). Briefly, CEHs were isolated as described above
and incubated on 60 mm petri dishes (Fisher Scientific). At 6 h



























g per plate. At 18 h of incubation, the transfection medium was
replaced with fresh medium containing corticosterone, insulin,




M). On some cells, the medium





(2.5 mM). At 66 h of incubation, CEHs were harvested and cell
extracts were prepared (31). CAT activity (32) and protein (33)
were assayed by the indicated methods. All DNAs used in transfec-
tion experiments were purified using the Qiagen endotoxin-free kit.
 
Preparation of membrane and nuclear extracts
 




C. To prevent proteolysis,
a mixture of protease inhibitors (Complete, Roche Molecular
Biochemicals) was included in all the buffers. Nuclear extracts
were prepared from CEHs by a modification of the method de-
scribed by Dignam et al. (34). Briefly, CEHs from four 100 mm









The resulting cell pellet was homogenized in Buffer 1 [10 mM




, 1 mM EDTA, 1 mM
EGTA, 1 mM dithiothreitol] using 20 strokes in a Dounce ho-





min, and the resulting nuclear pellet was washed once in buffer
1. The nuclear pellet was resuspended in Buffer 2 [20 mM Hepes
(pH 7.9), 420 mM NaCl, 25% (v/v) glycerol, 1.5 mM MgCl2, 1
mM EDTA, 1 mM EGTA, 1 mM dithiothreitol]. This suspension
was rotated for 30 min and then centrifuged 15,000 g for 30 min.
The resulting supernatant is designated as the nuclear extract
fraction. The membrane extract fraction was prepared by centri-
fuging the supernatant of the original 1,100 g spin for 1 h at
100,000 g. The resulting membrane pellet was dissolved in Buffer
3 [10 mM Tris (pH 6.8), 100 mM NaCl, 1% (w/v) SDS, 1 mM
EDTA, 1 mM EGTA, 1 mM dithiothreitol]. The protein content
of the nuclear and membrane extracts was determined as de-
scribed (33).
Gel mobility shift analysis
Double-stranded oligonucleotides were prepared by combin-
ing equal amounts of the complementary single-stranded DNA
in a solution containing 10 mM Tris (pH 8.0) and 1 mM EDTA
followed by heating to 90C for 2 min, and then cooling to room
temperature. The annealed oligonucleotides were labeled by fill-
ing in overhanging 5-ends using the Klenow fragment of Escheri-
chia coli DNA polymerase in the presence of [-32P]dCTP and/or
[-32P]dGTP. Binding reactions were carried out in 20 l of 20
mM Tris (pH 7.9), 100 mM KCl, 5 mM MgCl2, 1 mM EDTA, 1
mM dithiothreitol, 5% glycerol (v/v), 0.3 mg/ml BSA, and 2 g
of poly[d(I·C)]. A typical reaction contained 20,000 cpm of
labeled DNA and 20 g of nuclear extract. The reactions were
performed at 20C for 20 min (ACC SRE-1 probe) (Figs. 1A, B,
7B) or on ice for 60 min (ACC T3RE probe, Fig. 6). DNA and
DNA-protein complexes were resolved on 6% nondenaturing
polyacrylamide gels at 4C in 0.5 	 TBE (45 mM Tris (pH 8.3),
45 mM boric acid, 1 mM EDTA). Following electrophoresis,
the gels were dried and subjected to storage phosphor autora-
diography. For competition experiments, unlabeled competitor
DNA was mixed with radiolabeled oligomer prior to addition of
nuclear extract. For antibody supershift experiments, nuclear ex-
tracts were incubated with antibodies for 30 min prior to addi-
tion of the oligonucleotide probe. Mouse monoclonal antibodies
against SREBP-1 (IgG-2A4) and SREBP-2 (IgG-1D2) were ob-
tained from American Type Tissue Collection (Manassas, VA).




Proteins in nuclear extract and membrane fractions were sub-
jected to electrophoresis in 8% SDS-polyacrylamide gels and
then transferred to PDVF membranes (Amersham Pharmacia)
using an electroblotting apparatus (Owl Scientific). Immunoblot
analyses were performed as described in the Western blotting
protocol from Santa Cruz Biotechnology. Briefly, the blots were
blocked in Blotto [5% nonfat dry milk, 10 mM Tris-HCl (pH
8.0), 150 mM NaCl] at 4C overnight, and then incubated with
monoclonal antibody against SREBP-1 (IgG-2A4) diluted to 1
g/ml in Blotto containing 0.01% (v/v) Tween-20. After incuba-
tion with primary antibody for 1 h at room temperature, the
blots were washed in TBS [10 mM Tris-HCl (pH 8.0), 150 mM
NaCl] containing 0.01% Tween-20. Next, the blots were incu-
bated with a donkey anti-mouse IgG conjugated to horseradish
peroxidase (Jackson ImmunoResearch) diluted 1:10,000 in
Blotto, 0.01% Tween-20 for 1 h at room temperature. After wash-
ing with TBS, 0.01% Tween-20, antibody/protein complexes on
blots were detected using enhanced chemiluminescence (Amer-
sham Pharmacia). Chemiluminescence on the blots was visualized
using a FluorChem 8000 imager (Alpha Innotech Corporation),
and signals for the precursor and mature forms of SREBP-1 were
quantified using FluorChem V200 software.
RNase protection assay
A chicken SREBP-1 cDNA fragment (300 bp) containing se-
quences between nucleotides 829 and 1,128 relative to the start
site of translation was subcloned into the HindIII and BamHI sites
of pBluescript KS (Stratagene). The subclone was linearized with
BamHI, and antisense RNA was transcribed with -[32P]CTP (spe-
cific activity 3,000 Ci/mmol) using bacteriophage T3 RNA poly-
merase (Promega). An 18 S rRNA probe, which was used as a
control for RNA loading, was made from pRTI 18 S template
(Ambion, Austin, TX). Labeled RNAs were purified by polyacryl-
amide gel electrophoresis. RNA was extracted from CEH by the
guanidinium thiocyanate-phenol-chloroform method (35).
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RNase protection assays were performed using the RPA II kit (Am-
bion). Total RNA (20 g) was hybridized to 4 	 104 cpm of 32P-
labeled RNA at 45C for 16 h. The sample was then digested with a
mixture of RNase A and RNase T. Protected fragments were sepa-
rated on 8 M urea/5% polyacrylamide gels. Gels were dried and
subjected to storage phosphor autoradiography. Images were
quantified using ImageQuaNT software by Molecular Dynamics.
RESULTS
T3 and insulin increase the concentration of mature 
SREBP-1 in CEH
In a previous report, we showed that the mature form of
SREBP-1 interacted with TR on the ACC gene to en-
hance the stimulatory effect of T3 on ACC transcription
in CEH (10). This observation plus other work demon-
strating a role of T3 in signaling changes in dietary carbo-
hydrate status to lipogenic genes (1) have led us to hy-
pothesize that T3 modulates SREBP levels in CEH. As
insulin enhances the ability of T3 to activate ACC tran-
scription in CEH (24), we have further hypothesized that
insulin controls SREBP levels. As a first step in investigat-
ing these questions, gel mobility shift experiments were
performed to assess the binding of SREBP to the ACC
SRE-1 in CEH. Incubation of a 32P-labeled oligonucle-
otide probe containing the ACC SRE-1 (84 to 66 bp)
with nuclear extracts from CEH resulted in the formation
of three protein-DNA complexes (Fig. 1A, left panel). The
binding activity of the upper two complexes was specific,
insofar as it was competed by a 100-fold molar excess of
unlabeled ACC SRE-1 probe but not by a 100-fold molar
excess of an oligonucleotide containing an unrelated se-
quence. These complexes were designated a and b in the
order of increasing mobility. Preincubation of nuclear ex-
tract with an antibody against SREBP-1 disrupted the for-
mation of complex a but had no effect on the formation
of complex b. Preincubation of nuclear extract with an an-
tibody against SREBP-2 had no effect on the formation of
complex a and complex b. Incubation of the ACC SRE-1
probe with in vitro synthesized mature SREBP-1 (amino
acids 1 to 464) resulted in the formation of a SREBP-1 ho-
modimeric complex whose migration was identical to that
of complex a (Fig. 1A, right panel). Collectively, these
data suggest that complex a is comprised of SREBP-1 ho-
modimers and that SREBP-1 is the predominant isoform
of SREBP that binds ACC promoter 2 in CEH. The iden-
tity of the proteins in complex b is presently unclear. Previ-
ous work has shown that the SRE-1 binds multiple protein
complexes in crude nuclear extracts and that the tran-
scriptional activity of the SRE-1 is correlated only with the
binding of nuclear complexes containing SREBP (36, 37).
Thus, complex a containing SREBP-1 homodimers likely
accounts for the activity of the ACC SRE-1 in CEH.
In CEH incubated in the absence of hormones, the
binding of complex a to the ACC SRE-1 was barely de-
tectable (Fig. 1B). Addition of T3 or insulin to the culture
medium for 24 h stimulated an increase in the binding of
complex a. A greater stimulation of complex a binding ac-
tivity was observed when T3 and insulin were added to-
gether. Thus, T3 and insulin enhance the binding of
SREBP-1 to the ACC SRE-1 in CEH. To determine
whether the increase in SREBP-1 binding activity caused
by T3 and insulin was associated with an elevation in the
amount of mature SREBP-1, Western analyses were per-
formed using nuclear extracts from CEH. In CEH incu-
bated in medium containing high glucose (25 mM), treat-
ment with T3, insulin, or T3 plus insulin for 24 h
increased the concentration of mature SREBP-1 (Fig. 1C,
E). The extent of the increase in mature SREBP-1 concen-
tration caused by T3, insulin, and T3 plus insulin was 4.5-,
4.4-, and 7.0-fold, respectively. Similar effects of T3, insu-
lin, and T3 plus insulin on mature SREBP-1 levels were
observed when CEHs were incubated in medium contain-
ing low glucose (5 mM). Treatment of CEH with T3, insu-
lin, or T3 plus insulin in the presence of 5 mM glucose or
25 mM glucose also increased the level of precursor
SREBP-1 in membranes, but the extent of the effect of
these treatments (1.5- to 2.0-fold) was substantially less
than that observed for mature SREBP-1 (Fig. 1C, E). This
observation suggests that alterations in the synthesis of
precursor SREBP-1 account for part of the effects of T3
and insulin on mature SREBP-1 levels. T3 and insulin may
also modulate the proteolytic processing of precursor
SREBP-1 to mature SREBP-1 or the turnover of mature
SREBP-1.
The abundance of SREBP-1 mRNA was also measured
in CEH during different hormonal conditions. In CEH in-
cubated in medium containing 25 mM glucose, addition
of T3, insulin, or T3 plus insulin for 24 h increased the
abundance of SREBP-1 mRNA (Fig. 1D, E). The magni-
tude of the increase in SREBP-1 mRNA abundance caused
by T3, insulin, and T3 plus insulin was 2.0-, 1.6-, and 2.4-
fold, respectively. Similar effects of T3, insulin, and T3
plus insulin on SREBP-1 mRNA abundance were observed
in CEH incubated in medium containing 5 mM glucose.
These results provide further evidence that alterations in
the synthesis of precursor SREBP-1 account for part of the
increase in mature SREBP-1 concentration caused by T3
and insulin.
To further analyze the mechanism mediating the effects
of T3 and insulin on SREBP-1 levels in CEH, the time
course of the effects of T3, insulin, and T3 plus insulin on
the abundance of mature SREBP-1 protein, precursor
SREBP-1 protein, and SREBP-1 mRNA was determined in
CEH incubated in medium containing 25 mM glucose.
Treatment of CEH with T3 for 2 h had no effect on the
concentration of mature SREBP-1 (Fig. 2A, C). A small in-
crease in mature SREBP-1 concentration (1.5-fold) was
observed at 6 h of T3 treatment. A substantially larger in-
crease in mature SREBP-1 concentration (4.2-fold) was
observed at 24 h of T3 treatment. Longer incubations with
T3 did not result in a further stimulation of mature
SREBP-1 concentration (data not shown). The increase in
precursor SREBP-1 protein and SREBP-1 mRNA levels
caused by T3 was also maximal at 24 h of treatment. Incu-
bating CEH with T3 for 24 h increased the amount of pre-
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cursor SREBP-1 protein and SREBP-1 mRNA by 1.6- and
1.9-fold, respectively (Fig. 2).
In contrast to the delayed effect of T3 on the abundance of
mature SREBP-1, insulin caused a rapid increase in the abun-
dance of mature SREBP-1 in CEH. Treatment with insulin for
2 h stimulated a 3.3-fold increase in the concentration of
mature SREBP-1. Insulin also increased the concentration of
mature SREBP-1 at 6 h (3.4-fold) and 24 h (4.0-fold) of treat-
ment. The difference between T3 and insulin in the time
course of induction of mature SREBP-1 levels suggests that
these hormones act through different mechanisms to en-
hance the abundance of mature SREBP-1 in CEH. Whereas
insulin caused a substantial increase in the concentration of
mature SREBP-1 at 2 and 6 h of treatment, there was no effect
Fig. 1. 3,5,3-Triiodothyronine (T3) and insulin increase the concentration of mature sterol regulatory element binding protein (SREBP)-1 in
chick embryo hepatocytes (CEHs). Hepatocytes were isolated from livers of 18-day-old chick embryos and incubated in serum-free Waymouth’s
medium containing corticosterone and 5 mM glucose. At 18 h of incubation, the medium was changed to one of the same composition or to one
containing corticosterone and 25 mM glucose. T3, insulin, or T3 plus insulin was added at this time. At 42 h of incubation, cellular extracts or to-
tal RNA were prepared as described under Experimental Procedures. A: Gel mobility shift assays were per formed using nuclear extracts from
hepatocytes or in vitro synthesized mature SREBP-1 (amino acids 1 to 464) and an oligonucleotide probe containing the acetyl-CoA carboxylase-
(ACC) sterol regulatory element (SRE)-1 (84 to 66 bp). Positions of specific protein-DNA complexes (arrows) and nonspecific complexes
(asterisk) are indicated. Left panel: The ACC SRE-1 probe was incubated with nuclear extract from hepatocytes treated with T3 plus insulin in
the presence of 25 mM glucose. In some incubations, nuclear extract was incubated with antibodies against SREBP-1 or SREBP-2 prior to addi-
tion of the probe. Competition analysis was performed by mixing the labeled probe with a 100-fold molar excess of unlabeled probe (self compe-
tition) or unrelated sequence (nonspecific competition) prior to the addition of nuclear extract. Right panel: Comparison of the migration of
complex a with that of SREBP-1 dimers bound to the ACC SRE-1 probe. The ACC SRE-1 probe was incubated with in vitro synthesized mature
SREBP-1 or nuclear extract from hepatocytes treated with T3 plus insulin in the presence of 25 mM glucose. B: Gel mobility shift assays were per-
formed using the ACC SRE-1 probe and nuclear extracts from hepatocytes treated with T3, insulin, or T3 plus insulin in the presence of 25 mM
glucose. Positions of specific protein-DNA complexes (arrows) and nonspecific complexes (asterisk) are indicated. C: The abundance of precur-
sor SREBP-1 in membrane fractions and mature SREBP-1 in nuclear extracts was measured by Western analyses. These data are from a represen-
tative experiment. D: The abundance of SREBP-1 mRNA and 18S rRNA was measured using an RNase protection assay. These data are from a
representative experiment. E: Signals for precursor SREBP-1 protein and mature SREBP-1 protein from Western analyses and SREBP-1 mRNA
from RNase protection analyses were quantitated. Levels of precursor SREBP-1 protein, mature SREBP-1 protein, and SREBP-1 mRNA in hepato-
cytes treated with 5 mM glucose and no additional hormones were set at 1. Values are the means 
 SEM of four experiments. a: Mean is signifi-
cantly (P  0.05) different from that of cells treated with 5 mM glucose and no additional hormones. b: Mean is significantly (P  0.05) different
from that of cells treated with 25 mM glucose and no additional hormones. Experimental details for Western and RNase protection analyses are
described in Experimental Procedures.
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of this hormone on the concentration of SREBP-1 precursor
protein and SREBP-1 mRNA at these time points. This find-
ing suggests that most if not all of the increase in mature
SREBP-1 concentration caused by 2 and 6 h of insulin treat-
ment is mediated by changes in the processing of precursor
SREBP-1 to mature SREBP-1 or turnover of mature SREBP-1.
Incubating CEH with insulin for 24 h resulted in a small in-
crease (1.7-fold) in SREBP-1 mRNA abundance. This effect
may account for the slightly greater increase in mature
SREBP-1 levels at 24 h of insulin treatment relative to 2 and
6 h of insulin treatment. The time course of the effects of T3
plus insulin on the abundance of mature SREBP-1 protein,
precursor SREBP-1 protein, and SREBP-1 mRNA was similar
to that of insulin alone except that the magnitude of the ef-
fect of T3 plus insulin on mature SREBP-1 levels at 24 h of
treatment was greater than that of insulin alone at 24 h of
treatment. The latter observation is consistent with the pro-
posal that T3 increases the abundance of mature SREBP-1 via
a mechanism that is distinct from that mediating the increase
of mature SREBP-1 levels by insulin.
The ACC SRE-1 and T3RE constitute a response unit 
that mediates the inhibitory effects of cAMP and
medium-chain fatty acids on ACC transcription
Treatment of CEH with cAMP or medium-chain fatty ac-
ids inhibits the activation of ACC transcription caused by
T3 and insulin (24–26). Previous work demonstrating that
SREBP-1 interacts with TR to augment T3-induced ACC
transcription (10) plus results of the present study demon-
strating that T3 and insulin increases the concentration of
mature SREBP-1 (Figs. 1, 2) have led us to hypothesize
that SREBP-1 plays a role in mediating the inhibition of
ACC transcription by cAMP and medium-chain fatty acids.
To investigate this possibility, transient transfection experi-
ments were performed to identify the cis-acting sequences
that conferred the inhibitory effects of cAMP and hex-
anoate on ACC transcription in the presence of T3 and
insulin. In our initial experiments, CEHs were transfected
with a series of constructs containing 5-deletions of ACC
promoter 2 linked to the CAT gene. In CEH transfected
with a construct containing 4,900 bp of 5-flanking DNA
(p[ACC4900/274]CAT), cAMP and hexanoate de-
creased promoter activity by 72% and 51%, respectively
(Fig. 3). Deletion of ACC sequences to 2,054, 854,
391, and 212, 136, and 108 bp had no effect on
cAMP and hexanoate responsiveness. Deletion of se-
quences containing one of the half-sites of the ACC
T3RE (108 to 94 bp) abolished the hexanoate-mediated
inhibition of ACC transcription and diminished cAMP-
mediated inhibition of ACC transcription by 32%. This
deletion also decreased T3-induced ACC promoter activ-
ity by 95%. Further deletion of ACC sequences to 5-end
points of 84, 59, and 41 bp had no effect on residual
cAMP responsiveness. These data suggest that the ACC
T3RE between 101 and 86 bp is required for optimal
suppression of ACC transcription by cAMP and hex-
Fig. 2. Time course of the effects of T3 and insulin on levels of precursor SREBP-1 protein, mature SREBP-1 protein, and SREBP-1 mRNA
in CEH. Hepatocytes were isolated and incubated in serum-free Waymouth’s medium containing corticosterone and 25 mM glucose. At 18 h
of incubation, the medium was changed to one of the same composition. T3, insulin, or T3 plus insulin was added at this time. After 2, 6,
and 24 h of hormone treatment, cellular extracts or total RNA were prepared as described under Experimental Procedures. A: The abun-
dance of precursor SREBP-1 in membrane fractions and mature SREBP-1 in nuclear extracts was measured by Western analyses. These data
are from a representative experiment. B: The abundance of SREBP-1 mRNA and 18S rRNA was measured using an RNase protection assay.
These data are from a representative experiment. C: Signals for precursor SREBP-1 protein and mature SREBP-1 protein from Western anal-
yses and SREBP-1 mRNA from RNase protection analyses were quantitated. Levels of precursor SREBP-1 protein, mature SREBP-1 protein,
and SREBP-1 mRNA in hepatocytes treated with no additional hormones for 2 h were set at 1. Values are the means 
 SEM of four experiments.
a: Mean is significantly (P  0.05) different from that of cells incubated with no additional hormones for 2 h. b: Mean is significantly (P 
0.05) different from that of cells incubated with no additional hormones for 6 h. c: Mean is significantly (P  0.05) different from that of
cells incubated with no additional hormones for 24 h.
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anoate. In addition, ACC sequences downstream of 41
bp are also involved in conferring cAMP regulation on
ACC transcription.
To further analyze the role of the ACC T3RE in medi-
ating the actions of cAMP and hexanoate on ACC tran-
scription, CEHs were transfected with constructs contain-
ing fragments of the ACC gene linked to the minimal
promoter of the herpes simplex virus thymidine kinase
(TK) gene. The TK promoter alone was unresponsive to
cAMP and hexanoate (Fig. 4). When a DNA fragment
containing the ACC T3RE (108 to82 bp) was linked
to TKCAT, cAMP had no effect on promoter activity and
hexanoate caused a small decrease (20%) in promoter ac-
tivity. These results suggest that sequences in addition to
the ACC T3RE are required for optimal inhibition of
transcription by cAMP and hexanoate. When a DNA frag-
ment containing both the ACC T3RE and SRE-1 (108
to 66 bp) was linked to TKCAT, cAMP and hexanoate in-
hibited transcription by 52% and 60%, respectively. The
increase in cAMP and hexanoate responsiveness caused
by the inclusion of the ACC SRE-1 was not due to
changes in the spacing between the T3RE and the TK pro-
moter, because the effects of cAMP and hexanoate on a
construct containing a mutation of the ACC SRE-1 (SRE-1
mut) in the context of p[ACC108/66]TKCAT were
similar to those observed for p[ACC108/82]TKCAT.
In CEH transfected with a construct containing the SRE-1
alone (84 to 66 bp) linked to TKCAT, cAMP and hex-
anoate had no effect on promoter activity. Thus, the
ACC SRE-1 requires the presence of the ACC T3RE in
order to confer regulation of transcription by cAMP and
hexanoate. Collectively, the data in Figs. 3 and 4 suggest
that the ACC SRE-1 and T3RE constitute a response unit
that mediates the inhibitory effects of cAMP and hex-
anoate on gene transcription.
We next investigated the effects of the ACC SRE-1 on
the regulation of ACC promoter 2 by cAMP and hex-
anoate. Mutation of the ACC SRE-1 (79 to 72 bp) in
the context of the ACC promoter region extending from
108 to 274 bp decreased cAMP and hexanoate respon-
siveness by 43% and 61%, respectively (Fig. 5). A similar
result was obtained when the ACC SRE-1 was mutated in
the context of the ACC promoter region extending from
108 to 31. Thus, the presence of the ACC SRE-1 aug-
ments the inhibitory actions of cAMP and hexanoate on
ACC transcription. The observation that mutation of the
ACC SRE-1 does not completely inhibit cAMP respon-
siveness of ACC promoter 2 supports the 5-deletion data
(Fig. 3), suggesting the presence of an additional cAMP
response element(s) located downstream of 41 bp. The
Fig. 3. Effects of deletions of the 5-flanking region of ACC promoter 2 on transcriptional activity in the
absence and presence of cAMP or hexanoate. CEHs were transiently transfected with p[ACC4900/274]
chloramphenicol acetyltransferase (CAT) or equimolar amounts of other plasmids as described under Ex-
perimental Procedures. After transfection, cells were treated with T3 and insulin in the absence or presence
of dibutyryl cAMP or hexanoate for 48 h. Cells were then harvested, extracts prepared, and CAT assays per-
formed. Left: The constructs used in these experiments. The number at the left of each construct is the 5-
end of ACC DNA in nucleotides relative to the transcription initiation site of promoter 2. The 3-end of
each construct was 274 bp. The location of the T3 response element (T3RE) (101 to 86 bp) and SRE-1
(80 to 71 bp) is indicated by the vertical lines. Right: CAT activity of cells transfected with p[ACC212/
274]CAT and treated with T3 and insulin was set at 100, and the other activities were adjusted proportion-
ately. The effect of cAMP is the CAT activity of cells treated with T3, insulin, and cAMP expressed as a per-
centage of that in cells treated with T3 and insulin. The effect of hexanoate was calculated in a similar man-
ner. The effects of cAMP and hexanoate were calculated for individual experiments and then averaged. The
results are the means 
 SEM of six experiments. Significant differences between means within a column (P 
0.05) are as follows: a versus p[ACC108/274]CAT.
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3 boundary of this cAMP response element is probably
located upstream of 31 bp, because the activity of
p[ACC108/31]CAT containing the SRE-1 mutation is reg-
ulated by cAMP.
Effects of cAMP and hexanoate on the binding of nuclear 
proteins to the ACC T3RE and SRE-1
On the basis of the observation that the ACC T3RE is
required for optimal inhibition of ACC transcription by
cAMP and hexanoate (Figs. 3 and 4), we have hypothe-
sized that the effects of cAMP and hexanoate on ACC
transcription are mediated by alterations in the binding of
nuclear proteins to the ACC T3RE. Such changes in pro-
tein binding to the ACC T3RE would decrease the activ-
ity of the ACC T3RE per se and/or inhibit the ability of
the ACC T3RE to interact with the ACC SRE-1. To in-
vestigate this possibility, gel mobility shift analyses were
conducted using nuclear extracts from CEH incubated
with or without cAMP or hexanoate. We previously re-
ported that a probe containing the ACC T3RE (108 to
82 bp) bound to four complexes designated 1 to 4 in
the order of increasing mobility (5). Complexes 1, 2, and
3 contained LXR·RXR heterodimers, whereas complex 4
contained TR·RXR heterodimers. T3 treatment for 24 h
caused a marked increase in the binding of complex 3
and complex 4 and a decrease in the binding of complex
1 and complex 2. On the basis of these data, we have pro-
posed that T3-induced ACC transcription is mediated by
the binding of protein complexes containing TR·RXR
(complex 4) and LXR·RXR (complex 3). In Fig. 6 of the
present report, we show that addition of cAMP or hex-
anoate at the beginning or during the last 2 h of a 24 h in-
cubation with T3 and insulin has no effect on the binding
of complexes 1–4. These results suggest that the inhibi-
tory effects of cAMP and hexanoate on ACC transcrip-
tion are not mediated by alterations in protein binding to
the ACC T3RE.
Data in Figs. 4 and 5 indicate that cAMP and hexanoate
suppress the ability of the ACC SRE-1 to activate ACC
transcription in the presence of T3 and insulin. cAMP and
hexanoate may decrease the activity of the ACC SRE-1 by
suppressing the induction of mature SREBP-1 levels
caused by T3 and insulin. To investigate this possibility,
Western analyses were conducted using nuclear extracts
from CEH incubated in the absence or presence of cAMP
or hexanoate. Treatment of CEH with cAMP or hexanoate
during the last 2 h of a 24 h incubation with T3 and insu-
lin decreased the concentration of mature SREBP-1 (Fig.
7A, D). The extent of reduction in mature SREBP-1 con-
centration caused by cAMP and hexanoate was 71% and
52%, respectively. Similar results were obtained when
cAMP and hexanoate were added at the beginning of a 24 h
incubation with T3 and insulin. Further evidence that
cAMP and hexanoate decreased the concentration of ma-
ture SREBP-1 was obtained from gel mobility shift experi-
ments using the ACC SRE-1 as a probe. In CEH incu-
bated in the presence of T3 and insulin, addition of cAMP
or hexanoate decreased the binding activity of complex a
(Fig. 7B). These data suggest that cAMP and hexanoate
inhibit ACC SRE-1 activity by decreasing the concentra-
tion of mature SREBP-1.
To investigate the mechanism for the reduction in ma-
ture SREBP-1 levels caused by cAMP and hexanoate, the
abundance of precursor SREBP-1 protein and SREBP-1
mRNA was measured in CEH incubated in the absence or
presence of cAMP or hexanoate. Addition of cAMP or
hexanoate during the last 2 h of a 24 h incubation with T3
and insulin had no effect on the concentration of precur-
sor SREBP-1, whereas addition of cAMP or hexanoate at
the beginning of a 24 h incubation with T3 and insulin in-
creased the concentration of precursor SREBP-1 by 1.5- to
1.7-fold (Fig. 7A, D). Thus, the decrease in the concentra-
tion of mature SREBP-1 caused by cAMP and hexanoate is
not associated with a reduction in the concentration of
precursor SREBP-1, suggesting that a posttranslational
process is involved in mediating the effects of cAMP and
Fig. 4. The ACC T3RE and SRE-1 confer cAMP and hexanoate
responsiveness on a heterologous promoter. A: Sequence of the
chicken ACC gene between 108 and 66 bp. The hexameric
half-sites comprising the T3RE are indicated by arrows. The SRE-1
is boxed. The sequence of a block mutation of the SRE-1 (SRE-1
mut) is shown underneath the SRE-1. B: Fragments of the ACC
gene containing the T3RE and/or SRE-1 were linked to the mini-
mal thymidine kinase (TK) promoter in TKCAT. CEHs were tran-
siently transfected with these constructs and treated with T3 and in-
sulin in the absence or presence of dibutyryl cAMP or hexanoate as
described in the legend to Fig. 3 and under Experimental Proce-
dures. Left: Constructs used in these experiments. Numbers indi-
cate the 5 and 3 boundaries of ACC DNA relative to the tran-
scription initiation site of promoter 2. Right: CAT activity in CEH
transfected with p[ACC108/82]TKCAT and treated with T3
and insulin was set at 100, and the other activities were adjusted
proportionately. The effects of cAMP and hexanoate on promoter
activity were calculated as described in the legend to Fig. 3. The re-
sults are the means 
 SEM of six experiments. Significant differ-
ences between means within a column (P  0.05) are as follows:
a versus any other construct.
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hexanoate on mature SREBP-1 levels in CEH. We next in-
vestigated whether cAMP and hexanoate modulated the
abundance of SREBP-1 mRNA. Addition of cAMP be-
tween 1 and 24 h or between 22 and 24 h of a 24 h incuba-
tion with T3 and insulin had no effect on SREBP-1 mRNA
abundance (Fig. 7C, D). In contrast, addition of hex-
anoate during the last 2 h of a 24 h incubation with T3
and insulin decreased SREBP-1 mRNA abundance by
51%. Similar results were obtained when hexanoate was
added at the beginning of a 24 h incubation with T3 and
insulin. These data suggest that hexanoate also regulates
the concentration of mature SREBP-1 at a pretransla-
tional step.
DISCUSSION
Previous work from our laboratory has shown that
SREBP-1 interacts with TR on the ACC gene to enhance
T3-induced ACC transcription (10). In the present study,
we have identified a new interaction between the SREBP-1
and TR signaling pathways. T3 stimulates an increase in
the concentration of the mature, active form of SREBP-1
in CEH. These data are the first to show that T3 modu-
lates the activity of an accessory transcription factor that
controls TR activity.
An interesting feature of the regulation of the ACC
gene in CEH is that maximal activation of transcription by
T3 requires a relatively long time (24 h), with most of
the increase in transcription occurring between 5 h and
24 h of hormone treatment (24). Results of previous stud-
ies analyzing the binding of nuclear proteins to the ACC
T3RE have suggested that the increase in transcription be-
tween 5 and 24 h of T3 treatment is mediated by a de-
crease in the binding of protein complexes containing
LXR·RXR (complexes 1 and 2) and an increase in the
binding of protein complexes containing TR·RXR (com-
plex 4) and LXR·RXR (complex 3) (5). Results of time
course analyses in the present study suggest that alter-
ations in SREBP-1 binding to the ACC SRE-1 also play a
role in mediating the increase in ACC transcription
caused by T3. Addition of T3 increases the concentration
of mature SREBP-1 between 5 and 24 h of hormone treat-
ment (Fig. 2). The stimulatory effects of T3 on transcrip-
tion of fatty acid synthase (6), ATP-citrate lyase (38),
stearoyl-CoA desaturase (39), and spot 14 (40) may also
be mediated, at least in part, by the increase in mature
SREBP-1 abundance caused by T3, because these genes
contain functional SREs (11, 12, 18, 41, 42).
Previous studies have shown that the ability of T3 to ac-
tivate ACC transcription in CEH is enhanced by the pres-
ence of insulin in the culture medium (24). Data from the
present study indicate that insulin increases the concen-
tration of mature SREBP-1 in CEH and that this effect is
additive with that of T3 (Figs. 1, 2). This observation pro-
vides support for a role of SREBP-1 in mediating the ef-
fects of insulin on T3-induced ACC transcription. Other
mechanisms may be involved in mediating the actions of
insulin on ACC transcription, because most of the in-
crease in mature SREBP-1 levels caused by insulin is ob-
served within the first 2 h of insulin treatment (Fig. 2),
whereas most of the increase in ACC transcription caused
by T3 is observed between 5 and 24 h of T3 treatment (24).
In contrast to the chicken, two isoforms of SREBP-1,
designated as SREBP-1a and SREBP-1c, are expressed in
mammals (29). These different SREBP-1 isoforms vary in
structure at their N-termini and are derived from different
promoters on the SREBP-1 gene. SREBP-1c is the predom-
inant isoform of SREBP-1 expressed in liver; its activity is
subject to nutritional and hormonal regulation (15, 43,
44). In rat hepatocyte cultures, insulin increases the con-
centration of mature SREBP-1c (13–15). Thus, insulin has
Fig. 5. The ACC SRE-1 is required for optimal regulation of ACC promoter 2 activity by cAMP and hexanoate. p[ACC108/
274]CAT, p[ACC108/31]CAT, and constructs containing block mutations of the SRE-1 (SRE-1 mut) in the context of p[ACC108/
274]CAT or p[ACC108/31]CAT were transiently transfected into CEH as described under Experimental Procedures. After transfec-
tion, cells were treated with T3 and insulin in the absence or presence of dibutyryl cAMP or hexanoate as described in the legend to Fig. 3
and under Experimental Procedures. Left: The constructs used in these experiments. Numbers indicate the 5 and 3 boundaries of ACC
DNA in nucleotides relative to the transcription initiation site of promoter 2. Right: CAT activity of cells transfected with p[ACC108/
274]CAT and treated with T3 and insulin was set at 100, and the other activities were adjusted proportionately. The effects of cAMP and
hexanoate were calculated as described in the legend to Fig. 3. The results are the means 
 SEM of five experiments. Significant differences
between means within a column (P  0.05) are as follows: a versus p[ACC108/274]CAT; b versus p[ACC108/31]CAT.
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similar effects on the concentration of mature SREBP-1c
in rat hepatocytes and the concentration of mature
SREBP-1 in CEH. Further analyses have shown that insu-
lin-induced increase in mature SREBP-1c abundance in
rat hepatocytes is mediated primarily by changes in
SREBP-1c mRNA abundance (13–15). These findings con-
trast with those of the present study, suggesting that post-
translational processes play a prominent role in mediating
the effects of insulin on mature SREBP-1 levels in CEH.
The reason for the differences between avians and mam-
mals in the diversity of SREBP-1 isoforms and the mecha-
nism mediating the effects of insulin on mature SREBP-1
levels is not clear. They may reflect subtle class-dependent
differences in the role of SREBP-1 in the control of lipo-
genesis and/or other metabolic processes in liver.
In addition to participating in the activation of ACC tran-
scription by T3 and insulin, SREBP-1 plays a role in mediating
the inhibition of ACC transcription caused by cAMP. Results
from transfection, DNA binding, and Western analyses indi-
cate that cAMP inhibits ACC transcription in part by repress-
ing the ability of T3 and insulin to increase mature SREBP-1
levels (Figs. 3–5, 7). This effect, in turn, disrupts the positive
interaction between SREBP-1 and T3-bound TR on the
ACC gene. cAMP causes a rapid decrease (2 h) in mature
SREBP-1 concentration that precedes or parallels the reduc-
tion in ACC transcription caused by cAMP (24). To our
knowledge, these observations are the first to establish a role
for SREBP-1 in mediating the inhibitory effects of cAMP on li-
pogenic gene transcription.
cAMP inhibits the transcription of other lipogenic
genes, such as glucokinase, l-pyruvate kinase, fatty acid
synthase, malic enzyme, glycerol-3-phosphate acyltrans-
ferase, and spot 14 (1). For some of these genes, the
mechanism by which cAMP inhibits transcription has
been analyzed. For example, in rat hepatoma cells, the in-
hibitory actions of cAMP on fatty acid synthase transcrip-
tion are mediated by an inverted CCAAT box in the proxi-
mal promoter region of the fatty acid synthase gene (45).
This element constitutively binds the transcription factor,
nuclear factor-Y (46). How cAMP modulates nuclear fac-
tor-Y activity is presently not known. In CEH, inhibition of
malic enzyme transcription by cAMP is mediated by at
least four cis-acting elements in the malic enzyme 5-flanking
DNA (47). One of these elements binds c-Fos and activat-
ing transcription factor-2 in CEH incubated in the pres-
ence of cAMP. The mechanism by which c-Fos/activating
transcription factor-2 inhibits malic enzyme transcription
is presently not known. In rat hepatocytes, inhibition of
l-pyruvate kinase transcription by cAMP is mediated by
two contiguous cis-acting elements referred to as L3 and
L4 (48). These elements also mediate the stimulatory
effect of glucose on l-pyruvate kinase transcription. L3
binds the hepatocyte nuclear factor-4 (HNF-4) and L4
binds ChREBP (2, 49). Both HNF-4 and ChREBP activate
l-pyruvate kinase transcription. Recent work has shown
that protein kinase A phosphorylates ChREBP at Ser196
and Thr666, causing a block in the transport of ChREBP
from the cytoplasm to the nucleus and a decrease in the
binding of ChREBP to the L4 element (2). Protein kinase
A also phosphorylates HNF-4, causing a decrease in the
binding of HNF-4 to the L3 element (49). Thus, cAMP in-
hibits l-pyruvate kinase transcription by repressing the
stimulatory effects of HNF-4 and ChREBP on transcrip-
tion. These findings, in combination with those of the
present study, indicate that a wide variety of mechanisms
are involved in mediating the inhibitory actions of cAMP
on lipogenic gene transcription.
Results of the present study indicate that SREBP-1 also
plays a role in mediating the inhibitory effects of hex-
anoate on ACC transcription. As observed with cAMP,
hexanoate rapidly decreases (2 h) the concentration of
mature SREBP-1 in CEH incubated in the presence of T3
and insulin (Fig. 7). Results from Western and Northern
analyses suggest that the reduction in mature SREBP-1 lev-
els caused by hexanoate is mediated by both pretransla-
tional and posttranslational processes. In contrast, the in-
hibitory effect of cAMP on mature SREBP-1 levels appears
to be mediated solely by a posttranslational mechanism.
These observations suggest that hexanoate and cAMP act
through common as well as separate signaling pathways to
suppress mature SREBP-1 levels in CEH.
Recently, Kawaguchi et al. (16) have shown that acetate,
Fig. 6. Effect of cAMP and hexanoate on the binding of hepatic
nuclear proteins to the ACC T3RE. Eighteen hours after being
placed in culture, CEHs were incubated in Waymouth’s medium
containing corticosterone, insulin, and 25 mM glucose with or without
T3, T3 plus dibutyryl cAMP, or T3 plus hexanoate for the indicated
times. Cells were harvested and nuclear extracts were prepared as
described in Experimental Procedures. Nuclear extracts were sub-
jected to gel mobility shift analyses using an oligonucleotide probe
containing the ACC T3RE (108 to 82 bp). Specific protein-
DNA complexes are indicated by arrows. Previous studies have
shown that complexes 1, 2, and 3 contain liver X receptor
(LXR)·retinoid X receptor (RXR) heterodimers, whereas complex
4 contains nuclear T3 receptor (TR)·RXR heterodimers (5). These
data are representative of five experiments employing independent
preparations of nuclear extract.
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octanoate, and palmitate inhibit l-pyruvate kinase tran-
scription in rat hepatocytes by abolishing the binding of
ChREBP to the L4 element. This effect is mediated by an
increase in the phosphorylation of ChREBP at Ser568 by
AMP-activated protein kinase. Recent work by Zhou et al.
(50) suggests that AMP-activated protein kinase also con-
trols SREBP-1 activity. Treatment of rat hepatocytes with
agents that stimulate AMP-activated protein kinase activity
(5-amino-imidazole carboxamide riboside and the antidia-
betic drug, metformin) results in a reduction SREBP-1
protein levels and SREBP-1 mRNA abundance. These
agents also inhibit expression of ACC and fatty acid syn-
thase in rat hepatocytes (50, 51). We postulate that hex-
anoate decreases mature SREBP-1 levels in CEH by stim-
ulating the activity of AMP-activated protein kinase.
Alterations in AMP-activated protein kinase activity may
directly or indirectly regulate the activity of factors that
control the abundance of SREBP-1 mRNA and/or the
processing of precursor SREBP-1 to mature SREBP-1. Ex-
periments are underway to explore this hypothesis.
In addition to hexanoate and octanoate, long-chain
polyunsaturated fatty acids (PUFAs) inhibit lipogenic
gene transcription in hepatocytes incubated in the pres-
ence of insulin and T3 (52). In the case of the genes for
fatty acid synthase, stearoyl-CoA desaturase, and spot 14,
inhibition of transcription by PUFA is mediated, at least in
part, by a reduction in the concentration of mature
SREBP-1 (18, 41, 53). Further analyses have shown that
the decrease in mature SREBP-1 concentration caused by
PUFA is associated with a reduction in SREBP-1 mRNA
abundance (18, 20). The decrease in mature SREBP-1
concentration caused by hexanoate is also associated with
a reduction in SREBP-1 mRNA abundance (Fig. 7). On
the basis of these observations, we postulate that the active
metabolite(s) mediating the effect of PUFAs on SREBP-1
expression is similar to the metabolite mediating the ef-
fect of hexanoate on SREBP-1 expression. Further analysis
of the mechanisms by which medium-chain fatty acids and
PUFAs control SREBP-1 activity should aid in identifying
this metabolite.
In summary, we have shown that SREBP-1 is an acces-
sory transcription factor that plays an active and central
role in the hormonal and nutritional regulation of ACC
transcription in hepatocytes. Through interactions with
the TR, SREBP-1 functions as an integrator of multiple
stimulatory and inhibitory signals that influence rates of
lipogenesis. We propose that, in intact animals, this regu-
latory system allows for the rapid and fine control of
Fig. 7. cAMP and hexanoate suppress the stimulatory effects of T3 and insulin on the concentration of mature SREBP-1 in CEH. Eighteen
hours after being placed in culture, CEHs were incubated in Waymouth’s medium containing corticosterone, insulin, 25 mM glucose, and
T3 with or without dibutyryl cAMP or hexanoate for the indicated times. Cell extracts or total RNA were prepared as described in Experi-
mental Procedures. A: The abundance of precursor SREBP-1 in membrane fractions and mature SREBP-1 in nuclear extracts was measured
by Western analyses. These data are from a representative experiment. B: Gel mobility shift assays were per formed using nuclear extracts
from hepatocytes and an oligonucleotide probe containing the ACC SRE-1 (84 to 66 bp). Positions of specific protein-DNA complexes
(arrows) and nonspecific complexes (asterisk) are indicated. C: The abundance of SREBP-1 mRNA and 18S rRNA was measured using an
RNase protection assay. These data are from a representative experiment. D: Signals for precursor SREBP-1 protein and mature SREBP-1
protein from Western analyses and SREBP-1 mRNA from RNase protection analyses were quantitated. Levels of precursor SREBP-1 protein,
mature SREBP-1 protein, and SREBP-1 mRNA in hepatocytes treated with T3 and insulin without cAMP and hexanoate were set at 1. Values
are the means 
 SEM of four experiments. a: mean is significantly (P  0.05) different from that of cells treated with T3 and insulin without
cAMP and hexanoate.
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ACC transcription in response to alterations in dietary
carbohydrate intake.
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